Originalsprog | Engelsk |
---|---|
Publikationsdato | sep. 2020 |
Status | Udgivet - sep. 2020 |
Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial
A. S. Christensen, S. Haedersdal, J. Stoy, H. Storgaard, U. Kampmann, M. Seghieri, J. J. Holst, T. Hansen, F. K. Knop, T. Vilsboll